dc.contributor.author | Vandecasseye, Willy | |
dc.contributor.author | Fryns, Jean-Pierre | |
dc.contributor.author | Sciot, Raf | |
dc.contributor.author | Massa, Guy | |
dc.contributor.author | Denayer, Ellen | |
dc.contributor.author | Devriendt, Koen | |
dc.contributor.author | de Ravel, Thomy | |
dc.contributor.author | Van Buggenhout, Griet | |
dc.contributor.author | Smeets, Eric | |
dc.contributor.author | Francois, Inge | |
dc.contributor.author | Sznajer, Yves | |
dc.contributor.author | Craen, Margarita | |
dc.contributor.author | Leventopoulos, George | |
dc.contributor.author | Mutesa, Leon | |
dc.contributor.author | Kayserili, Hulya | |
dc.contributor.author | Legius, Eric | |
dc.date.accessioned | 2021-03-05T16:48:45Z | |
dc.date.available | 2021-03-05T16:48:45Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Denayer E., Devriendt K., de Ravel T., Van Buggenhout G., Smeets E., Francois I., Sznajer Y., Craen M., Leventopoulos G., Mutesa L., et al., "Tumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations", GENES CHROMOSOMES & CANCER, cilt.49, ss.242-252, 2010 | |
dc.identifier.issn | 1045-2257 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_c270188d-23c0-469e-ba78-aec771835337 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/129046 | |
dc.identifier.uri | https://doi.org/10.1002/gcc.20735 | |
dc.description.abstract | Noonan syndrome (NS) is an autosomal dominant disorder caused by mutations in PTPN11, KRAS, SOS1, and RAF1 We performed SOS1, RAF1, BRAF MEK1, and MEK2 mutation analysis in a cohort of 102 PTPN11- and KRAS-negative NS patients and found pathogenic SOS1 mutations in 10, RAF1 mutations in 4, and BRAF mutations in 2 patients. Three novel SOS1 mutations were found. One was classified as a rare benign variant and the other remains unclassified. We confirm a high prevalence of pulmonic stenosis and ectodermal abnormalities in SOS1-positive patients. Three patients with SOS1 mutations presented with tumors (embryonal rhabdomyosarcoma, Sertoli cell testis tumor, and granular cell tumors of the skin). One patient with a RAF1 mutation had a lesion suggestive for a giant cell tumor. This is the first report describing different tumor types in ISIS patients with germ line SOS1 mutations. (C) 2009 Wiley-Liss, Inc. | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Tıbbi Genetik | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Temel Bilimler | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | GENETİK VE HAYAT | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.title | Tumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations | |
dc.type | Makale | |
dc.relation.journal | GENES CHROMOSOMES & CANCER | |
dc.contributor.department | KU Leuven , , | |
dc.identifier.volume | 49 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 242 | |
dc.identifier.endpage | 252 | |
dc.contributor.firstauthorID | 195493 | |